UNICA IRIS Institutional Research Information System

MANTOVANI, GIOVANNI
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 32.417
NA - Nord America 2.859
AS - Asia 482
SA - Sud America 6
AF - Africa 1
OC - Oceania 1
Totale 35.766
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 31.634
US - Stati Uniti d'America 2.840
CN - Cina 322
UA - Ucraina 270
SE - Svezia 193
GB - Regno Unito 90
SG - Singapore 87
DE - Germania 86
FI - Finlandia 68
KR - Corea 35
FR - Francia 26
IN - India 26
CA - Canada 19
BE - Belgio 16
ES - Italia 8
NL - Olanda 8
RU - Federazione Russa 6
IR - Iran 5
JP - Giappone 4
BO - Bolivia 2
BR - Brasile 2
IE - Irlanda 2
LT - Lituania 2
PT - Portogallo 2
RO - Romania 2
AR - Argentina 1
AU - Australia 1
BG - Bulgaria 1
CH - Svizzera 1
EC - Ecuador 1
GR - Grecia 1
HK - Hong Kong 1
KZ - Kazakistan 1
MU - Mauritius 1
PL - Polonia 1
TW - Taiwan 1
Totale 35.766
Salva come PNG Salva come JPEG
Città #
Cagliari 30.593
Uta 864
Fairfield 407
Woodbridge 265
Chandler 231
Ashburn 210
Houston 199
Seattle 190
Nyköping 181
Boardman 159
Wilmington 153
Jacksonville 152
Cambridge 151
Ann Arbor 149
Dearborn 64
Santa Clara 56
Singapore 54
Shanghai 53
Nanjing 49
Boston 45
Beijing 38
Guangzhou 32
Seoul 28
Helsinki 24
New York 22
San Diego 22
Pune 21
London 19
Changsha 18
Los Angeles 17
Brussels 16
Toronto 16
Shenyang 15
Nanchang 12
Jiaxing 11
Milan 10
Rome 10
Redwood City 9
Tianjin 9
Norwalk 8
Jinan 7
Orange 7
San Mateo 7
Auburn Hills 6
Hangzhou 6
Kunming 6
Verona 6
Barcelona 5
Brandizzo 5
Hebei 5
Hefei 5
Munich 5
Sassari 5
Augusta 4
Kilburn 4
Mountain View 4
Somma Vesuviana 4
Torino 4
Wuhan 4
Amsterdam 3
Chicago 3
Detroit 3
Florence 3
Fuzhou 3
Islington 3
Leawood 3
Monmouth Junction 3
Ningbo 3
Salerno 3
Zhengzhou 3
Acton 2
Cerignola 2
Chiswick 2
Chuncheon 2
Cosenza 2
Costa Masnaga 2
Costa Mesa 2
Dublin 2
Espoo 2
Harbin 2
Hounslow 2
Manitou Springs 2
Muenster 2
Ottawa 2
Qingdao 2
Quanzhou 2
Redmond 2
Reggello 2
San Giorgio in Bosco 2
Santa Cruz 2
Santana de Parnaíba 2
Shenzhen 2
Sobrado de Paiva 2
Sordio 2
Tonara 2
Valencia 2
Vitulazio 2
Washington 2
Xian 2
Yazd 2
Totale 34.774
Salva come PNG Salva come JPEG
Nome #
Timing of the negative effects of trastuzumab on cardiac mechanics after anthracycline chemotherapy 3.451
The cachexia score (CASCO) as a tool for staging cachectic cancer patients 2.106
Muscle wasting as main evidence of energy impairment in cancer cachexia: future therapeutic approaches 1.966
Advances in pharmacologic strategies for cancer cachexia 1.803
Open phase II study on efficacy and safety of an oral amino acid functional cluster supplementation in cancer cachexia 1.688
The nutritional risk in oncology: a study of 1,453 cancer outpatients 1.649
Randomised phase III clinical trial of 5 different arms of treatment for patients with cancer-related anorexia/cachexia syndrome (CACS) 1.440
null 936
Palonosetron plus dexamethasone effectively prevents acute and delayed chemotherapy-induced nausea and vomiting following highly or moderately emetogenic chemotherapy in pre-treated patients who have failed to respond to a previous antiemetic treatment: Comparison between elderly and non-elderly patient response 873
Design, conduct, and analyses of Breast International Group (BIG) 1-98: a randomized, double-blind, phase-III study comparing letrozole and tamoxifen as adjuvant endocrine therapy for postmenopausal women with receptor-positive, early breast cancer 866
Bone fractures among postmenopausal patients with endocrine-responsive early breast cancer treated with 5 years of letrozole or tamoxifen in the BIG 1-98 trial 842
Screening the nutritional status in oncology: a preliminary report on 1,000 outpatients 822
null 819
Letrozole therapy alone or in sequence with tamoxifen in women with breast cancer 787
Current medications for cancer cachexia 740
Subcutaneous interleukin-2 in combination with medroxyprogesterone acetate and antioxidants in advanced cancer responders to previous chemotherapy: phase II study evaluating clinical, quality of life, and laboratory parameters 721
Immunotherapy (recombinant interleukin 2), hormone therapy (medroxyprogesterone acetate) and antioxidant agents as combined maintenance treatment of responders to previous chemotherapy 690
null 681
Dose-intense phase II study of weekly cisplatin and epidoxorubicin plus medroxyprogesterone acetate and recombinant interleukin 2 in stage IIIB-IV non-small cell lung cancer 656
Neo-adjuvant chemo-(immuno-)therapy of advanced squamous-cell head and neck carcinoma: a multicenter, phase III, randomized study comparing cisplatin + 5-fluorouracil (5-FU) with cisplatin + 5-FU + recombinant interleukin 2 631
Phase II study of subcutaneously administered interleukin-2 in combination with medroxyprogesterone acetate and antioxidant agents as maintenance treatment in advanced cancer responders to previous chemotherapy 553
null 529
Phase II clinical trial of local use of GM-CSF for prevention and treatment of chemotherapy- and concomitant chemoradiotherapy-induced severe oral mucositis in advanced head and neck cancer patients: An evaluation of effectiveness, safety and costs 522
Clinical and immunological evaluation of schizophyllan (SPG) in combination with standard chemotherapy in patients with head and neck squamous cell carcinoma 485
Six-week induction chemotherapy followed by concomitant chemoradiation therapy in stage IV head and neck cancer: a phase II study with organ-sparing purposes 466
Phase II study of induction chemotherapy followed by concomitant chemoradiotherapy in advanced head and neck cancer: clinical outcome, toxicity and organ/function preservation 454
Cytokine activity in cancer-related anorexia/cachexia: role of megestrol acetate and medroxyprogesterone acetate 452
Medroxyprogesterone acetate reduces the in vitro production of cytokines and serotonin involved in anorexial/cachexia and emesis by peripheral blood mononuclear cells of cancer patients 444
Efficacy, compliance and prognostic significance of a comprehensive geriatric assessment in the geriatric cancer patient = Efficacia, applicabilità e significato prognostico di una valutazione geriatrica multidimensionale nel paziente oncologico anziano 427
Cisplatin induces serotonin release from human peripheral blood mononuclear cells of cancer patients and methylprednisolone inhibits this effect 427
Role of proinflammatory cytokines and leptin in cancer-related anorexia/cachexia. Metabolic abnormalities and therapeutic approaches = Ruolo delle citochine infiammatorie e della leptina nell'anoressia/cachessia neoplastica. Aspetti metabolici e terapeutici 426
A phase II study with antioxidants, both in the diet an supplemented, pharmaco-nutritional support, progestagen and anti-COX-2 showing efficacy and safety in patients with cancer-related anorexia-cachexia and oxidative stress 424
Assessment of the efficacy of two dosages and schedules of human recombinant erythropoietin in the prevention and correction of cisplatin-induced anemia in cancer patients 420
Medroxyprogesterone acetate and megestrol acetate reduce cisplatin-induced serotonin release from human peripheral blood mononuclear cells of cancer patients 412
Phase II study of induction chemotherapy followed by concomitant chemoradiotherapy in advanced head and neck cancer: clinical response and organ/function preservation 411
Neo-adjuvant organ-preserving chemotherapy in the management of locally advanced oral cavity and oropharynx cancer: A tentative quantitative evaluation of organ preservation and clinical response 409
Relationships betxween Fas expression, activation molecule CD25, and functional activity of tumor-associated lymphomonocytes from neoplastic effusions 394
Tumor-associated lymphomonocytes from neoplastic effusions are immunologically defective in comparison with patient autologous PBMCs but are capable of releasing high amounts of various cytokynes 383
Medroxyprogesterone acetate reduces the production of cytokines and serotonin involved in anorexia/cachexia and emesis by peripheral blood mononuclear cells of cancer patients 380
Neo-adjuvant (primary) organ-preserving chemotherapy in the management of locally advanced laryngeal carcinoma: Larynx preservation and clinical response 357
Tumor-associated lymphocytes (TAL) are competent to produce higher levels of cytokines in neoplastic pleural and peritoneal effusions than those found in sera and are able to release into culture higher levels of IL-2 and IL-6 than those released by PBMC 352
Docetaxel and cisplatin in locally advanced or metastatic squamous-cell carcinoma of the head and neck: a phase II study of the Southern Italy Cooperative Oncology Group (SICOG) 315
Anorexia/Cachexia and oxidative stress in cancer patients = Anoressia/Cachessia e stress ossidativo nei pazienti con cancro 310
Peripheral blood lymphocyte response to exogenous interleukin 2 by PHA-prestimulated and non-PHA-prestimulated cells in patients with cancer 256
An innovative treatment approach for cancer-related anorexia/cachexia and oxidative stress: Background and design of an ongoing, phase III, randomized clinical trial 240
Membrane-bound and soluble IL-2 receptors (p55 and p75 chains) on peripheral blood mononuclear cells from patients with solid malignancies 218
Medroxyprogesterone acetate reduces the In vitro production of cytokines and serotonin involved in anorexia/cachexia and emesis by peripheral blood mononuclear cells of cancer patients 190
[p55 and p75 subunits of the IL 2 receptor, membrane bound and soluble, in peripheral lymphocytes in patients with solid tumors] 171
Membrane-bound/soluble IL-2 receptor (IL-2R) and levels of IL-1α, IL-2, and IL-6 in the serum and in the PBMC culture supernatants from 17 patients with hematological malignancies 127
Megestrol acetate in neoplastic anorexia/cachexia: clinical evaluation and comparison with cytokine levels in patients with head and neck carcinoma treated with neoadjuvant chemotherapy 116
Comparison of granisetron, ondansetron, and tropisetron in the prophylaxis of acute nausea and vomiting induced by cisplatin for the treatment of head and neck cancer: a randomized controlled trial 104
Comparison of oral 5-HT3-receptor antagonists and low-dose oral metoclopramide plus i.m. dexamethasone for the prevention of delayed emesis in head and neck cancer patients receiving high-dose cisplatin 102
Lack of correlation between defective cell-mediated immunity and levels of secreted or circulating cytokines in a study of 90 cancer patients 83
Preovulatory human follicular fluid in vitro inhibits interleukin (IL)- 1α, IL-2, and production and expression of p55 chain IL-2 receptor of lymphomonocytes 80
Immunologic assessment determined by response to IL-2 and immunophenotyping of tumor-infiltrating lymphocytes, of invaded and non invaded lymph nodes and of peripheral blood lymphocytes from twenty-one patients with primary laryngeal cancer 77
Study of peripheral blood lymphocyte subset distribution and IL-2 receptor (IL-2 R) p55-p75 subunit expression in patients with cancer of different sites 72
[The immunological assessment of a combined therapeutic approach (chemo- + radiotherapy +/- surgery) including immunotherapy in neoplasms of the head and neck area at an advanced stage] 70
Evidence that granulosa cells inhibit interleukin-1α and interleukin-2 production from follicular lymphomonocytes 54
Totale 35.879
Salva come PNG Salva come JPEG
Categoria #
all - tutte 52.888
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 52.888
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20206.184 0 0 0 0 2.270 1.774 855 286 215 141 175 468
2020/20218.700 336 338 447 2.022 1.861 1.235 831 663 143 335 369 120
2021/20221.351 108 104 90 69 157 83 60 91 120 103 158 208
2022/20232.479 186 235 193 178 175 292 72 475 166 148 212 147
2023/20243.698 250 132 132 275 365 669 396 237 204 356 315 367
2024/20253.256 394 813 854 774 421 0 0 0 0 0 0 0
Totale 35.879